Join Massive Bio at the ASCO Annual Meeting 2025
Visit Us at Booth IH04
Come meet the Massive Bio team at Booth IH04 and learn how we’re reshaping cancer clinical trial access for patients, providers, and partners across the world.
Live demo of our AI-powered platform
Discover our global reach and multilingual capabilities
Explore partnership opportunities across pharma, CROs, and providers
Talk with our medical and data science experts
Visit Us at Booth IH04
Come meet the Massive Bio team at Booth IH04 and learn how we’re reshaping cancer clinical trial access for patients, providers, and partners across the world.
Live demo of our AI-powered platform
Discover our global reach and multilingual capabilities
Explore partnership opportunities across pharma, CROs, and providers
Talk with our medical and data science experts
What We’re Showcasing
AI-Powered Matching
Our platform uses real-time data from EMRs, genomics, and clinical profiles to match patients with active clinical trials with speed and accuracy.
Global Reach, Local Relevance
Massive Bio has onboarded over 160,000 patients and matched more than 19,000 to clinical trials through its AI-powered platform across 17 markets. We partner with 45 pharma and CRO organizations, collaborate with 400+ advocacy groups, and work with 130+ strategic partners to expand global trial access.
Recruitment & Feasibility at Scale
We combine real-world evidence and predictive analytics to support trial feasibility, enrollment, and patient identification across rare and common cancers.
What We’re Showcasing
AI-Powered Matching
Our platform uses real-time data from EMRs, genomics, and clinical profiles to match patients with active clinical trials with speed and accuracy.
Global Reach, Local Relevance
Massive Bio has onboarded over 160,000 patients and matched more than 19,000 to clinical trials through its AI-powered platform across 17 markets. We partner with 45 pharma and CRO organizations, collaborate with 400+ advocacy groups, and work with 130+ strategic partners to expand global trial access.
Recruitment & Feasibility at Scale
We combine real-world evidence and predictive analytics to support trial feasibility, enrollment, and patient identification across rare and common cancers.
Dr. Arturo Loaiza-Bonilla at ASCO25
Catch Dr. Arturo Loaiza-Bonilla, Co-Founder and Chief Medical Officer, as he presents on the role of AI in transforming clinical trial matching and cancer research infrastructure.
Sessions
- Poster Session: Clinical trial matching with multi-agent AI and oncology-specific knowledge graph
June 1 | 9:00 AM–12:00 PM | Abstract 1554, Board 320 - ASCO/ESMO Joint Podium Session: Patient-centric pre-screening hubs through digital innovation
June 2 | 1:15–2:30 PM CDT | Room S102 & On Demand
Featured Publications
- ASCO Educational Book: AI-enabled multidisciplinary oncology
- NEJM AI Perspective: Human-AI collaboration in clinical care
Dr. Arturo Loaiza-Bonilla at ASCO25
Catch Dr. Arturo Loaiza-Bonilla, Co-Founder and Chief Medical Officer, as he presents on the role of AI in transforming clinical trial matching and cancer research infrastructure.
Sessions
- Poster Session: Clinical trial matching with multi-agent AI and oncology-specific knowledge graph
June 1 | 9:00 AM–12:00 PM | Abstract 1554, Board 320 - ASCO/ESMO Joint Podium Session: Patient-centric pre-screening hubs through digital innovation
June 2 | 1:15–2:30 PM CDT | Room S102 & On Demand
Featured Publications
- ASCO Educational Book: AI-enabled multidisciplinary oncology
- NEJM AI Perspective: Human-AI collaboration in clinical care
Massive Bio helps cancer patients around the world gain access to clinical trials of innovative new oncology treatments that can help create better outcomes. Our mission is to help all cancer patients in need, regardless of where they live or their financial circumstances.
Massive Bio’s Clinical Network, powered by artificial intelligence, accurately matches patients to clinical trials using key factors such as diagnostic details, geographic location, medical history, and biomarker status. We guide your patient through every step of the process, keeping you informed throughout and ensuring they are connected to the most appropriate clinical trial option available.
Our latest solution DUO—an advanced physician surfacing tool designed for pharmaceutical commercial teams. DUO provides timely, data-driven insights by delivering real-time trigger alerts, enriched physician profiles including diagnostic and prescribing patterns, and access to de-identified clinical data on patients who may be candidates for therapies within a given portfolio.
MASSIVE BIO’S GLOBAL IMPACT
Selin Kurnaz, PhD, CEO of Massive Bio
“At Massive Bio, our mission goes beyond conventional approaches—we use AI-powered technology to connect cancer patients with clinical trials that fit their unique profiles. By supporting oncologists, patients, and sponsors with real-time insights and streamlined processes, we help accelerate clinical research and expand access. Our goal is simple: ensure that every patient, regardless of location or background, has timely access to the most relevant clinical trial options.”
MASSIVE BIO’S GLOBAL IMPACT
Selin Kurnaz, PhD, CEO of Massive Bio
“At Massive Bio, our mission goes beyond conventional approaches—we use AI-powered technology to connect cancer patients with clinical trials that fit their unique profiles. By supporting oncologists, patients, and sponsors with real-time insights and streamlined processes, we help accelerate clinical research and expand access. Our goal is simple: ensure that every patient, regardless of location or background, has timely access to the most relevant clinical trial options.”
Let’s Connect
Book a 1:1 meeting with our team at ASCO25 to discuss how we can work together to accelerate access, reduce trial enrollment timelines, and drive impact.
Use the hashtags #ASCO25 and #ClinicalTrials to join the conversation.
Let’s Connect
Book a 1:1 meeting with our team at ASCO25 to discuss how we can work together to accelerate access, reduce trial enrollment timelines, and drive impact.
Use the hashtags #ASCO25 and #ClinicalTrials to join the conversation.
Follow the Action
Questions?
Reach out to us at support@massivebio.com or call +1 844-627-7246. We’re ready to talk.
This content is independently produced by Massive Bio. References to the 2025 ASCO® Annual Meeting are for informational purposes only. ASCO® is a registered trademark of the American Society of Clinical Oncology. This site is not affiliated with or endorsed by ASCO. Poster content reflects the authors’ views, not those of ASCO.